Fig. 1From: Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needsCholinesterase activity levels indicating liver regeneration in a chronic HCV patient treated with IBDV; Legend: A striking feature of the superinfection therapy (SIT) was the regeneration of the cirrhotic liver over several years of follow upBack to article page